← Open Payments lookup

NPI 1366606923: Open Payments

NPI 1366606923. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$188 in 9 payments from 8 companies in 2025. Trend: 2023 $104 · 2024 $53 · 2025 $188

Food & beverage: $188
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc2$44
Novo Nordisk Inc1$29
Neurocrine BioSciences, Inc.1$22
Alkermes, Inc.1$21
Collegium Pharmaceutical, Inc.1$20
Otsuka America Pharmaceutical, Inc.1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Exact Sciences Corporation1$16

Products named: INVEGA SUSTENNA, Ozempic, INGREZZA, ARISTADA, Belbuca, ABILIFY ASIMTUFII, CAPLYTA, Cologuard Collection Kit.